Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 1
2010 1
2011 1
2012 2
2013 1
2014 3
2015 2
2016 1
2018 5
2019 7
2020 2
2021 3
2022 3
2023 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer.
Tempfer C, Brucker S, Juhasz-Boess I, Mallmann P, Steiner E, Denschlag D, Hillemanns P, Wallwiener M, Beckmann MW; Uterus Commission of the AGO. Tempfer C, et al. Among authors: juhasz boess i. Geburtshilfe Frauenheilkd. 2023 Sep 12;83(9):1095-1101. doi: 10.1055/a-2145-1545. eCollection 2023 Sep. Geburtshilfe Frauenheilkd. 2023. PMID: 38230409 Free PMC article.
Therapy for Primary Vulvar Carcinoma.
Herr D, Juhasz-Boess I, Solomayer EF. Herr D, et al. Among authors: juhasz boess i. Geburtshilfe Frauenheilkd. 2014 Mar;74(3):271-275. doi: 10.1055/s-0033-1360145. Geburtshilfe Frauenheilkd. 2014. PMID: 24882877 Free PMC article.
Correction to: Teaching undergraduate students gynecological and obstetrical examination skills: the patient's opinion.
Hamza A, Warczok C, Meyberg-Solomayer G, Takacs Z, Juhasz-Boess I, Solomayer EF, Radosa MP, Radosa CG, Stotz L, Findeklee S, Radosa JC. Hamza A, et al. Among authors: juhasz boess i. Arch Gynecol Obstet. 2022 Aug;306(2):577. doi: 10.1007/s00404-021-06324-z. Arch Gynecol Obstet. 2022. PMID: 34783895 Free PMC article. No abstract available.
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021).
Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, Haase H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Thiel F, Ulrich UA, Vogl T, Vordermark D, Wallwiener M, Gass P, Beckmann MW. Denschlag D, et al. Among authors: juhasz boess i. Geburtshilfe Frauenheilkd. 2022 Dec 1;82(12):1337-1367. doi: 10.1055/a-1897-5124. eCollection 2022 Dec. Geburtshilfe Frauenheilkd. 2022. PMID: 36467974 Free PMC article.
38 results